Skip Nav Destination

First Edition

Research Article March 21 2025

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling

Ryan S. Humphrey,Seohee Nam,Dennis C. Wylie,Lauren I. R. Ehrlich

Research Article March 11 2025

Discovery of a novel class NSD2 inhibitor for t(4;14)-positive multiple myeloma

Sae Matsuoka,Naoki Osada,Hirokazu Kubota,Ko Kikuzato,Hiroo Koyama,Takeshi Sonoda,Akiko Idei,Minoru Yoshida,Masaki Kikuchi,Takashi Umehara,Chiduru Watanabe,Teruki Honma,Hiroshi Yasui,Sho Ikeda,Naoto Takahashi,Hideki Nakasone,Jiro Kikuchi,Yusuke Furukawa

View article

Supplementary data

Research Article March 10 2025

Improved survival with daratumumab-CyBorD compared to CyBorD as Frontline Therapy In AL Amyloidosis

View article

Supplementary data

Brief Report March 10 2025

Genomic Landscape and Clonal Architecture in Pediatric Myeloid Neoplasms with Chromosome 7 Deletions

Tamara Westover,Michael P. Walsh,Sherif Abdelhamed,Emily Xiong,Jing Ma,Guangchun Song,Melvin Thomas,Masayuki Umeda,Jamie L. Maciaszek,Jasmine C. Wong,Astrid Wintering,Lu Wang,Peter D. Emanuel,Mignon L. Loh,Sarah K. Tasian,Elliot Stieglitz,Jason R. Schwartz,Kevin M. Shannon,Jeffery M. Klco

View article

Supplementary data

Review Article March 10 2025

Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation

Hannah Kunstek,Janneke Kieviet,Caroline Lindemans,Coco de Koning,Stefan Nierkens

View article

Research Article March 10 2025

Retrospective Evaluation of R-EPOCH in the Frontline Treatment of Adult PTLD Patients Following Solid Organ Transplant

Brian Cuzzo,Maegan Ford,Saagar Jain,Hua-Jay Cherng,Evelyn Orlando,Patrick Gould,Amy Song,Benjamin May,Yuxuan Chen,Govind Bhagat,Andrew H. Lipsky,Barbara Pro,Jennifer E. Amengual

View article

Brief Report March 6 2025

Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms

View article

Supplementary data

Research Article March 3 2025

Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance

Matthew R.M. Jotte,Angela Stoddart,Tanner C. Martinez,Raven Moten,Yuqing Xue,Molly K. Imgruet,Hunter Blaylock,Henna S. Nam,Bonnie Hu,Jermaine Austin,Ningfei An,Saira Khan,Sandeep K. Gurbuxani,Megan E. McNerney

View article

Supplementary data

Research Article March 3 2025

TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasms

View article

Supplementary data

Brief Report March 3 2025

Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis

Katie Erdos,Aya Alshareef,Richard T. Silver,Joseph M. Scandura,Ghaith Abu-Zeinah

View article

Supplementary data

Research Article March 3 2025

Phase 2 trial of daratumumab, cyclophosphamide, thalidomide and dexamethasone in newly diagnosed multiple myeloma

Edvan de Queiroz Crusoe,Joanna Suzana Leal Ribeiro dos Santos,Juliana de Andrade Santos,Herbert Henrique de Melo Santos,Allan de Souza Santos,Larissa Ferreira Lucas,Cristiane Almeida Requião de Pinna,Paula Nogueira Caldas Freire,Adriano Araujo de Jesus,Alessandro de Moura Almeida,Daniela Dourado Dutra,Marcos Fonseca Chaves,Jamile Souza Nicanor,Marco Aurelio Salvino,Maria da Gloria Bomfim Arruda,Vania Hungria,on behalf of GBRAM

View article

Supplementary data

Research Article March 3 2025

Phase 1 Trial of Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone for AML and High-Grade Myeloid Neoplasm

Suravi Raychaudhuri,Ted A. Gooley,Allegra Rasmussen,Kim Quach,Eva Gill,Anna B. Halpern,Jacob S. Appelbaum,Cristina M. Ghiuzeli,Paul C. Hendrie,Ryan D. Cassaday,Roland B. Walter,Mary-Elizabeth M. Percival

View article

Supplementary data

Brief Report March 3 2025

Prospective Clinical Trials of Venetoclax and Hypomethylating Agents for Relapsed BPDCN

Naveen Pemmaraju,Luan Phan,Geoffrey Fell,Marlise R. Luskin,Mahesh Swaminathan,Sherry Pierce,Courtney DiNardo,Abhishek Maiti,Marina Konopleva,Andrew A Lane

View article

Brief Report February 21 2025

A Novel Three-Way Translocation Involving ETV6::IL3 Drives AML with Eosinophilia

View article

Supplementary data

Research Article February 21 2025

Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: A SEER-Medicare analysis

Dai Chihara,Shibing Yang,Savreet Bains Chawla,Guihua Zhang,Anthony Wang,Junhua Yu,Donald Arnette,Fernando Rivas Navarro,Julie Blaedel,Alex Mutebi

View article

Supplementary data

Research Article February 16 2025

Prognostic Impact of RDI of Vincristine in Patients with DLBCL Receiving R-CHOP: A Supplementary Analysis of JCOG0601

Takahiro Nakashima,Tomotaka Suzuki,Ryunosuke Machida,Kazuyuki Shimada,Tsutomu Kobayashi,Dai Maruyama,Wataru Munakata,Shinsuke Iida,Ken Ohmachi,Tomohiro Kinoshita,Kiyoshi Ando,Hirokazu Nagai

View article

Supplementary data

Research Article February 16 2025

Single cell sequencing reveals shared clonal signatures in non-malignant B- and tumor cells in T-prolymphocytic leukemia

Caroline Hesselager,Ingrid Thörn,Millaray Marincevic,Claes Ladenvall,Jonas Almlöf,Sara Löfgren,Simone Weström,Helena Nord,Lesley-Ann Sutton,Lucia Cavelier,Panagiotis Baliakas,Rose-Marie Amini

View article

Supplementary data

Research Article February 16 2025

Adult Leukemia in Florida 2010-2019: Diverse, Aging Population as an Indicator for the United States

Ming S. Lee,Rebecca E. Kaiser,Christopher D. Armstrong,David B. Dukenik,Nancy S. Elliott,Raymond R. Balise,Justin M. Watts,Mikkael A. Sekeres,Erin N. Kobetz,Justin Taylor

View article

Brief Report January 27 2025

Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study

View article

Research Article January 23 2025

A Phase II Study of Decitabine with or without Carboplatin and Arsenic Trioxide in MDS and AML Patients

Patricia L. Kropf,Woonbok Chung,Raji Shameem,Lianchun Xiao,Curt Balch,Xuelin Huang,Jean-Pierre J. Issa

View article

Supplementary data

Research Article January 20 2025

A feedforward loop between ACLY and MYC supports T-ALL progression in vivo

Victoria da Silva-Diz,Amartya Singh,Maya Aleksandrova,Oekyung Kim,Christopher Thai,Olga Lancho,Patricia Renck Nunes,Hayley Affronti,Alexia Martínez de Paz,Steven Z. Josefowicz,Xiaoyang Su,Kathryn E. Wellen,Daniel Herranz

View article

Supplementary data

Research Article January 16 2025

Clarithromycin, Ixazomib, Pomalidomide, Dexamethasone for Relapsed/Refractory Myeloma: Survival and Correlative Analysis

Aaron S Rosenberg,Emanual Maverakis,Caitlin Costello,Elizabeth A. Brem,Matthew Joseph Wieduwilt,Guillaume Luxardi,Paul Kaesberg,Keon Abedi,Samantha Herbert,Joseph Tuscano

View article

Supplementary data

First Edition

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling

Discovery of a novel class NSD2 inhibitor for t(4;14)-positive multiple myeloma

Improved survival with daratumumab-CyBorD compared to CyBorD as Frontline Therapy In AL Amyloidosis

Genomic Landscape and Clonal Architecture in Pediatric Myeloid Neoplasms with Chromosome 7 Deletions

Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation

Retrospective Evaluation of R-EPOCH in the Frontline Treatment of Adult PTLD Patients Following Solid Organ Transplant

Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms

Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance

TYK2 is essential for the therapeutic effect of IFN-α in Jak2V617F-induced murine myeloproliferative neoplasms

Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis

Phase 2 trial of daratumumab, cyclophosphamide, thalidomide and dexamethasone in newly diagnosed multiple myeloma

Phase 1 Trial of Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone for AML and High-Grade Myeloid Neoplasm

Prospective Clinical Trials of Venetoclax and Hypomethylating Agents for Relapsed BPDCN

A Novel Three-Way Translocation Involving ETV6::IL3 Drives AML with Eosinophilia

Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: A SEER-Medicare analysis

Prognostic Impact of RDI of Vincristine in Patients with DLBCL Receiving R-CHOP: A Supplementary Analysis of JCOG0601

Single cell sequencing reveals shared clonal signatures in non-malignant B- and tumor cells in T-prolymphocytic leukemia

Adult Leukemia in Florida 2010-2019: Diverse, Aging Population as an Indicator for the United States

Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study

A Phase II Study of Decitabine with or without Carboplatin and Arsenic Trioxide in MDS and AML Patients

A feedforward loop between ACLY and MYC supports T-ALL progression in vivo

Clarithromycin, Ixazomib, Pomalidomide, Dexamethasone for Relapsed/Refractory Myeloma: Survival and Correlative Analysis

ASH Publications

American Society of Hematology

First Edition

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only